Canopy Growth Corporation (CGC)
NASDAQ: CGC · Real-Time Price · USD
0.9571
-0.0101 (-1.04%)
At close: Jun 22, 2026, 4:00 PM EDT
0.9700
+0.0129 (1.35%)
After-hours: Jun 22, 2026, 7:52 PM EDT
Canopy Growth Revenue
In the fiscal year ending March 31, 2026, Canopy Growth had annual revenue of 284.60M CAD with 5.80% growth. Canopy Growth had revenue of 71.25M in the quarter ending March 31, 2026, with 9.56% growth.
Revenue (ttm)
284.60M CAD
Revenue Growth
+5.80%
P/S Ratio
2.03
Revenue / Employee
296,461 CAD
Employees
960
Market Cap
414.34M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 284.60M | 15.61M | 5.80% |
| Mar 31, 2025 | 269.00M | -28.15M | -9.47% |
| Mar 31, 2024 | 297.15M | -36.11M | -10.83% |
| Mar 31, 2023 | 333.25M | -142.45M | -29.94% |
| Mar 31, 2022 | 475.70M | -70.95M | -12.98% |
| Mar 31, 2021 | 546.65M | 147.88M | 37.08% |
| Mar 31, 2020 | 398.77M | 172.43M | 76.18% |
| Mar 31, 2019 | 226.34M | 148.39M | 190.37% |
| Mar 31, 2018 | 77.95M | 38.05M | 95.38% |
| Mar 31, 2017 | 39.90M | 27.20M | 214.16% |
| Mar 31, 2016 | 12.70M | 10.33M | 435.60% |
| Mar 31, 2015 | 2.37M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Tilray Brands | 858.28M |
| Emergent BioSolutions | 676.80M |
| Organogenesis Holdings | 514.70M |
| Esperion Therapeutics | 418.24M |
| Ironwood Pharmaceuticals | 361.51M |
| Evolus | 301.79M |
| Akebia Therapeutics | 232.40M |
| Kamada | 181.68M |
CGC News
- 5 days ago - 3 Marijuana Stocks Investors Can See Returns On Before The End Of The Year - MarijuanaStocks
- 6 days ago - Canopy Growth price target lowered to C$1.60 from C$1.80 at Alliance Global - TheFly
- 6 days ago - CGC Q4 Earnings Call Focuses on EBITDA Path - Nasdaq
- 6 days ago - Where Will Canopy Growth Be in 5 Years? - The Motley Fool
- 7 days ago - Canopy Growth Corporation (WEED:CA) Reports Q4 Fiscal 2026 Results and Strategic Initiatives - GuruFocus
- 7 days ago - Canopy Growth Reports 300.0% Wider Q4 2026 Loss at -$0.40/Share - AlphaStreet
- 7 days ago - Canopy Growth Q4 Earnings Call Highlights - MarketBeat
- 7 days ago - Canopy Growth Earnings Call Transcript: Q4 2026 - Transcripts